Episode 1 with Dr. Timothy Vollmer on maintaining brain health
Links to articles and other resources mentioned in Episode 1
Methods
“No great discovery was ever made without a bold guess,” Sir Isaac Newton
There’s an urgent need to find answers for the more than one million people living with progressive MS
There’s an urgent need to find answers for the more than one million people living with progressive MS
As researchers, we know how exciting it is when this axiom comes true, especially when...
Clinical Research, Laboratory Research
MS Research Roundup: January 15, 2014
Surprising Alcohol Finding; Bigger, Better Patient Research Databases; Start-Up Lessons; MS and Obamacare
Surprising Alcohol Finding; Bigger, Better Patient Research Databases; Start-Up Lessons; MS and Obamacare
Items of interest to multiple sclerosis researchers from around the Web
Clinical Research, Laboratory Research, Methods, People
MS Research Roundup: April 23, 2014
Human Versus Mouse Microglia; Teva Suffers Setback in Generic Copaxone Fight; Motley Fool Loves Biogen Idec
Human Versus Mouse Microglia; Teva Suffers Setback in Generic Copaxone Fight; Motley Fool Loves Biogen Idec
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research
International Progressive MS Alliance Announces New Research Grants
An international group committed to advancing research and treatment in progressive MS has announced €22 million in grants
An international group committed to advancing research and treatment in progressive MS has announced €22 million in grants
The International Progressive MS Alliance today announced its first round of 22 grants to...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People
MS Research Roundup: February 18, 2015
Carbon Nanoparticles for MS; #HackMS Stands for Big Data and More; Restoring Myelin in Irradiated Brains; Lemon Verbena for MS Tea Time
Carbon Nanoparticles for MS; #HackMS Stands for Big Data and More; Restoring Myelin in Irradiated Brains; Lemon Verbena for MS Tea Time
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research
Why TH17 Cells Turn to the Dark Side
Study identifies protein that spurs potential MS culprit to become pathogenic
Study identifies protein that spurs potential MS culprit to become pathogenic
Whenever a criminal gets arrested, everyone asks why he went bad. Was it his upbringing? Did he...
Laboratory Research
Small Internal Jugular Veins Linked to Severe MS
Small internal jugular veins with restricted outflow, but not CCSVI per se, are linked to severe MS
Small internal jugular veins with restricted outflow, but not CCSVI per se, are linked to severe MS
The presence of small internal jugular veins with restricted outflow, but not chronic cerebrospinal venous insufficiency...
Clinical Research
Teriflunomide, Interferon β-1a Show Comparable Efficacy
A phase 3 head-to-head study found no difference in annualized relapse rate between teriflunomide 14 mg and interferon β-1a
A phase 3 head-to-head study found no difference in annualized relapse rate between teriflunomide 14 mg and interferon β-1a
Teriflunomide can be considered a reasonable alternative to interferon β-1a in treating patients with relapsing forms of multiple sclerosis...
Clinical Research
Clinical Risk Calculator for MS: How Close Are We?
Decoding MS risk factors is less like fitting together a jigsaw puzzle and more like balancing a Jenga tower, with layer upon layer of complex interactions and unpredictable outcomes if something changes
Decoding MS risk factors is less like fitting together a jigsaw puzzle and more like balancing a Jenga tower, with layer upon layer of complex interactions and unpredictable outcomes if something changes
When we need it, we have the Framingham risk assessment tool to determine our risk for...
Clinical Research